Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-25-014941·LoConti Joseph E.
Schedule 13D ownership disclosure
VITALITY BIOPHARMA
COMMON STOCK · CUSIP: 92849B107
Event date: 2025-09-23
- Filing-level shares
- 26,645,789.00
- Percent of class
- 23.73%
- Joseph E. LoContiReported CIK 0001025708
Shares: 26,645,789.00 · Class: 23.73%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-014941
- Form type
- SCHEDULE 13D/A
- Filer
- LoConti Joseph E.
- CIK
- CIK 1025708
- Filed
- Sep 25, 2025
- Reporting period
- Sep 23, 2025
- Description
- Schedule 13D beneficial ownership